Lipid/Metabolic
Treat risk and not LDL-cholesterol targets, new perspective argues
16 COMMENT S - Jan 19, 2012 11:00 EST
In focusing on patient risk, rather than LDL-cholesterol treatment targets, doctors would improve patient outcomes and reduce adverse effects and costs that result from treating low-risk, low-benefit patients, say experts.

Ann Arbor, MI and New Haven, CT - In an open letter to the writing committee of the upcoming cholesterol guidelines, two physicians are calling for the abandonment of treating to LDL-cholesterol targets and instead recommending that the new guidelines focus on a more tailored treatment approach that takes into account overall cardiovascular risk [1]. In focusing on global risk, rather than LDL-cholesterol levels, doctors would improve patient outcomes and reduce adverse effects and costs that result from treating low-risk, low-benefit patients.
Read full article »

Medscape Medical News
Sitagliptin/metformin once-daily combo approved for diabetes
Feb 3, 2012 18:00 EST

Prevention
Photos on school lunch trays boost veggie intake
Feb 3, 2012 15:45 EST

Features
The flap over flavonoids
Feb 2, 2012 15:15 EST

Prevention
"Cardiovascular health," new focus of the AHA, linked with reduced mortality
Feb 1, 2012 16:15 EST

Medscape Medical News
Stroke risk linked to infections in children
Feb 1, 2012 09:00 EST

Medscape Medical News
Combination type 2 diabetes pill gets FDA nod
Jan 31, 2012 17:30 EST

Editorial programs
Debate and dialogue between top cardiovascular specialists, produced by
theheart.org's editorial team
View all »
Salt, hypertension, and prevention
Salt, hypertension, and prevention
7 COMMENTS - Jan 16, 2012 08:24 EST
AIM-HIGH falls short on niacin debate
AIM-HIGH falls short on niacin debate
7 COMMENTS - Dec 14, 2011 11:00 EST
PCI survey
PCI survey
Dec 12, 2011 11:38 EST
Resource Center (view all)

What's New